Prodeon Medical, Inc.
Paul M. Edwards has a diverse work experience spanning various roles and industries. Paul M. is currently the President, CEO, and Director of Prodeon Medical, Inc. Prior to that, they founded their own private management consulting firm, P.M. Edwards Consulting, LLC, where they served as the Managing Director. Paul M. also worked at Amicomed as the SVP of US Strategy, Partnerships & Alliances and at Launchpad Digital Health, LLC as a General Operating Partner. Additionally, they have held positions as the Managing Director at Hercules Capital, Inc., the V.P. of Corporate & Business Development at IntegenX, Inc., and as a Principal at Latterell Venture Partners. Edwards has also served as a member of the Board of Directors for Transcend Medical, Promed, and Ovalis.
Paul M. Edwards holds an MBA in Finance & Entrepreneurial Studies from the University of Minnesota - Carlson School of Management. Paul M. also has a Bachelor of Science (BS) in Pre-Medicine/Pre-Medical Studies (Biological Sciences and Chemistry) from Florida State University.
This person is not in any offices
Prodeon Medical, Inc.
Our program was initially started in 2016 with the mission of reimagining how men can be more easily treated for one of the most common disease states in the world affecting men, Benign Prostatic Hyperplasia (BPH). Prodeon Medical, Inc. has developed and is investigating a minimally invasive and patient-friendly approach to treating Lower Urinary Tract Symptoms (LUTS) due to BPH The procedure, known as the PURE™ (Prostatic Urethral REshaping) procedure uses the investigational the Urocross™ Expander System and Retrieval Sheath to relieve symptoms associated with BPH. Caution: The Urocross Expander System and Retrieval Sheath are for investigational use only under the Expander-2 Clinical Trial (NCT: 05400980) and are not for sale in the U.S. or outside the U.S.